Vapotherm, Inc. is a privately held company that develops, manufactures, and markets respiratory devices. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification.

UCD provided a Human Factors evaluation of a new CPAP machine being developed by Vapotherm prior to its submission to the FDA. The Human Factors evaluation included operational evaluation of the equipment for ease of use as well as safety.